Literature DB >> 21553231

Significantly high expression of platelet-derived growth factor (PDGF) in benign nodules of the thyroid: relevance in the development of goitre recurrence?

Patrizia Malkomes1, Elsie Oppermann, Wolf-Otto Bechstein, Katharina Holzer.   

Abstract

PURPOSE: Platelet-derived growth factor (PDGF) is a critical regulator of cell proliferation and influences the development of tumors. The role of PDGF in benign thyroid diseases is presently not well-determined. The purpose is to evaluate PDGF isoforms and receptors in primary culture of thyrocytes isolated from human thyroid tissue.
METHODS: Forty patients with uninodular (n = 11), multinodular (n = 15) and recurrent goitre (n = 14) were investigated. Nodular and corresponding paranodular thyroid tissues were characterized. RNA and protein were extracted from primary thyrocyte monoculture. RT-PCR, western blot and ELISA were performed to evaluate PDGF isoforms AA, BB, CC, DD and PDGF receptors α and β.
RESULTS: Significantly higher mRNA expression of PDGF-AA, -BB, -CC and PDGFR molecules α and β was measured by RT-PCR in thyrocytes from uninodular and recurrent nodular tissue compared with corresponding paranodular tissue. Elevated PDGF protein and PDGFR-α and -β were confirmed by western blot. Likewise, higher secretion of PDGF-AA and -BB was detected in the supernatant of thyrocyte culture from all nodular tissue compared with paranodular tissue. Interestingly, comparison of nodular and corresponding paranodular tissues in multinodular goitre did not show significant difference of expression levels of PDGF isoforms or receptors.
CONCLUSION: These findings suggest that the overexpression of PDGF isoforms and receptors may play a crucial role in the development of thyroid nodules and recurrent goitre.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553231     DOI: 10.1007/s00423-011-0799-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  35 in total

Review 1.  The PDGF family: four gene products form five dimeric isoforms.

Authors:  Linda Fredriksson; Hong Li; Ulf Eriksson
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

Review 2.  [From diffuse goiter to nodular goiter].

Authors:  M Derwahl
Journal:  Internist (Berl)       Date:  1998-06       Impact factor: 0.743

Review 3.  Platelet-derived growth factor.

Authors:  C H Heldin; A Wasteson; B Westermark
Journal:  Mol Cell Endocrinol       Date:  1985-03       Impact factor: 4.102

4.  Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase.

Authors:  D Wang; H J Huang; A Kazlauskas; W K Cavenee
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

5.  An investigation of epidemiologic factors associated with large nodular goiter.

Authors:  R Phitayakorn; D M Super; C R McHenry
Journal:  J Surg Res       Date:  2006-06-01       Impact factor: 2.192

6.  An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.

Authors:  Kuei-Tien Chen; Jen-Der Lin; Miaw-Jene Liou; Hsiao-Fen Weng; C Allen Chang; Err-Cheng Chan
Journal:  Cancer Lett       Date:  2005-08-29       Impact factor: 8.679

Review 7.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Authors:  Daniel J Hicklin; Lee M Ellis
Journal:  J Clin Oncol       Date:  2004-12-07       Impact factor: 44.544

8.  Recurrence after total thyroidectomy for benign multinodular goiter.

Authors:  Kylie L Snook; Peter L H Stalberg; Stan B Sidhu; Mark S Sywak; Pamela Edhouse; Leigh Delbridge
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

Review 9.  Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature.

Authors:  Jacob Moalem; Insoo Suh; Quan-Yang Duh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

10.  Molecular characterization of PDGFR-alpha/PDGF-A and c-KIT/SCF in gliosarcomas.

Authors:  Rui M Reis; Albino Martins; Susana A Ribeiro; Diana Basto; Adhemar Longatto-Filho; Fernando C Schmitt; José M Lopes
Journal:  Cell Oncol       Date:  2005       Impact factor: 6.730

View more
  6 in total

1.  Endemic goiter--individual risk factors necessitate individual treatment.

Authors:  M Schneider; T Welsch; M Kremer; M W Büchler
Journal:  Langenbecks Arch Surg       Date:  2011-12       Impact factor: 3.445

2.  PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration.

Authors:  Huan-Yong Che; Hang-Yuan Guo; Xu-Wei Si; Qiao-Ying You; Wei-Ying Lou
Journal:  Tumour Biol       Date:  2014-05-28

3.  Surgery for recurrent goiter: complication rate and role of the thyroid-stimulating hormone-suppressive therapy after the first operation.

Authors:  P Miccoli; G Frustaci; A Fosso; M Miccoli; G Materazzi
Journal:  Langenbecks Arch Surg       Date:  2014-11-29       Impact factor: 3.445

Review 4.  Targeting the PDGF signaling pathway in tumor treatment.

Authors:  Carl-Henrik Heldin
Journal:  Cell Commun Signal       Date:  2013-12-20       Impact factor: 5.712

5.  The Role of Vitamin D, Platelet-Derived Growth Factor and Insulin-Like Growth Factor 1 in the Progression of Thyroid Diseases.

Authors:  Mona S Abdellateif; Sabry Shaarawy; Yasmine F Elesawy; Mona Mansour; Effat Tharwat; Noha H Ibrahim; Marwa S Eissa
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

6.  Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motility.

Authors:  Huan-Yong Che; Hang-Yuan Guo; Xu-Wei Si; Qiao-Ying You; Wei-Ying Lou
Journal:  Onco Targets Ther       Date:  2014-03-14       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.